De Chao Yu
Chief Executive Officer bij INNOVENT BIOLOGICS, INC.
Vermogen: 526 M $ op 31-03-2024
Profiel
De Chao Yu is oprichter van Innovent Biologics, Inc. en Chengdu Kanghong Pharmaceutical Group Co., Ltd. Hij is voorzitter en Chief Executive Officer bij Innovent Biologics, Inc. en voorzitter van de Chinese Antibody Society. Hij zit ook in de raad van bestuur van Babytree Group en Cheerwin Group Ltd. en is professor aan de Universiteit van Sichuan. De Chao Yu was voorheen President & Chief Executive Officer van Chengdu Kanghong Pharmaceutical Group Co., Ltd., Vice-President-Research & Development van Applied Genetic Technologies Corp., Vice-President-Research & Development van Applied Genetics, Inc., President & Chief Executive Officer van Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd., Vice President-Research & Development voor Calyon North America, Inc., Vice President bij Calydon, Inc. en Managing Director bij China Medicinal Biotech Association. Hij behaalde een doctoraat aan de Chinese Academie van Wetenschappen.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INNOVENT BIOLOGICS, INC.
6.73% | 22-03-2024 | 109 245 165 ( 6.73% ) | 526 M $ | 31-03-2024 |
Actieve functies van De Chao Yu
| Bedrijven | Functie | Begin |
|---|---|---|
| INNOVENT BIOLOGICS, INC. | Chief Executive Officer | 28-04-2011 |
| Sichuan University | Corporate Officer/Principal | 01-01-2008 |
| Chinese Antibody Society | Chairman | 01-01-2017 |
Eerdere bekende functies van De Chao Yu
| Bedrijven | Functie | Einde |
|---|---|---|
| BABYTREE GROUP | Director/Board Member | 10-05-2023 |
| CHEERWIN GROUP LIMITED | Director/Board Member | 14-10-2022 |
| China Medicinal Biotech Association | Corporate Officer/Principal | 01-01-2019 |
| PHARMABLOCK SCIENCES (NANJING), INC. | Director/Board Member | 01-01-2018 |
| CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD | Chief Executive Officer | 01-01-2011 |
Opleiding van De Chao Yu
| Chinese Academy of Sciences | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 5 |
|---|---|
| CHENGDU KANGHONG PHARMACEUTICAL GROUP CO., LTD | Health Technology |
| INNOVENT BIOLOGICS, INC. | Health Technology |
| PHARMABLOCK SCIENCES (NANJING), INC. | Commercial Services |
| BABYTREE GROUP | Commercial Services |
| CHEERWIN GROUP LIMITED | Process Industries |
| Bedrijven in privébezit | 7 |
|---|---|
Calydon, Inc.
 Calydon, Inc. Medical SpecialtiesHealth Technology Part of ANI Pharmaceuticals, Inc., Calydon, Inc. develops therapeutic products for cancer. The private company is based in Sunnyvale, CA. Calydon was acquired by Cell Genesys, Inc. on September 05, 2001 for $17.68 million. | Health Technology |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Calyon North America, Inc.
 Calyon North America, Inc. Regional BanksFinance Part of SAS Rue la Boétie, Calyon North America, Inc. is a private company based in New York, NY. | Finance |
| China Medicinal Biotech Association | |
| Applied Genetics, Inc. | |
Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd.
 Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ellimist Singapore Pte Ltd., Kanghong Sagent Chengdu Pharmaceutical Corp. Ltd. is a pharmaceutical company that manufactures and supplies pharmaceutical products. The private company is based in Chengdu, China. Kanghong Sagent Chengdu Pharmaceutical Corp. was acquired by Sagent Pharmaceuticals, Inc., part of Ellimist Singapore Pte Ltd. from February 28, 2023 on June 04, 2013 for $4.06 million. The Chinese company was founded in 2006. | Health Technology |
| Chinese Antibody Society |
